Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
+5.97%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$10.8B
AUM Growth
-$573M
(-5%)
Cap. Flow
-$872M
Cap. Flow
% of AUM
-8.04%
Top 10 Holdings %
Top 10 Hldgs %
15.46%
Holding
577
New
157
Increased
112
Reduced
119
Closed
154
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$148M |
| 2 |
Skyworks Solutions
SWKS
|
+$122M |
| 3 |
Equitable Holdings
EQH
|
+$115M |
| 4 |
Target
TGT
|
+$113M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$109M |
Top Sells
| 1 |
IBM
IBM
|
+$155M |
| 2 |
NXP Semiconductors
NXPI
|
+$138M |
| 3 |
Salesforce
CRM
|
+$132M |
| 4 |
PF
Pinnacle Foods, Inc.
PF
|
+$120M |
| 5 |
Akamai
AKAM
|
+$114M |
Sector Composition
| 1 | Technology | 19.87% |
| 2 | Industrials | 16.28% |
| 3 | Energy | 11.93% |
| 4 | Financials | 11.89% |
| 5 | Healthcare | 11.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Galmed Pharmaceuticals
GLMD
$8M
| $2.08M | 0.02% |
+972
| New | +$2.08M |
|
327
Origin Bancorp
OBK
$1.22B
| $2.07M | 0.02% |
+50,589
| New | +$2.07M |
|
328
KALA BIO
KALA
$102M
| $2.06M | 0.02% |
3,002
+96
| +3% | +$65.8K |
|
|
NITE
329
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $2.05M | 0.02% |
127,977
+4,093
| +3% | +$65.5K |
|
330
Q32 Bio
QTTB
$21.3M
| $2.04M | 0.02% |
5,556
-1,111
| -17% | -$408K |
|
331
Universal Technical Institute
UTI
$1.5B
| $2M | 0.02% |
634,291
+20,280
| +3% | +$63.9K |
|
332
Potbelly
PBPB
$386M
| $1.96M | 0.02% |
151,061
-278,439
| -65% | -$3.61M |
|
|
NCNA
333
NuCana
NCNA
$5.57M
| $1.95M | 0.02% |
20
| – | – |
|
|
TECD
334
DELISTED
Tech Data Corp
TECD
| $1.93M | 0.02% |
+23,516
| New | +$1.93M |
|
335
Neuronetics
STIM
$223M
| $1.86M | 0.02% |
+70,000
| New | +$1.86M |
|
|
ALDR
336
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $1.81M | 0.02% |
114,528
+53,663
| +88% | +$848K |
|
337
Gilead Sciences
GILD
$144B
| $1.75M | 0.02% |
24,658
-1,165,501
| -98% | -$82.6M |
|
338
ITT
ITT
$13.5B
| $1.72M | 0.02% |
+32,889
| New | +$1.72M |
|
339
MeiraGTx Holdings
MGTX
$601M
| $1.72M | 0.02% |
+150,000
| New | +$1.72M |
|
|
ACER
340
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
| $1.64M | 0.01% |
76,009
-13,389
| -15% | -$289K |
|
341
Vericel Corp
VCEL
$1.68B
| $1.62M | 0.01% |
+167,421
| New | +$1.62M |
|
342
Amicus Therapeutics
FOLD
$2.46B
| $1.61M | 0.01% |
103,304
+3,304
| +3% | +$51.6K |
|
|
FTSV
343
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $1.6M | 0.01% |
+100,000
| New | +$1.6M |
|
|
ATHN
344
DELISTED
Athenahealth, Inc.
ATHN
| $1.59M | 0.01% |
+10,011
| New | +$1.59M |
|
|
NTGN
345
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $1.58M | 0.01% |
+125,000
| New | +$1.58M |
|
346
Carisma Therapeutics
CARM
$17.3M
| $1.48M | 0.01% |
+38,023
| New | +$1.48M |
|
347
Kiniksa Pharmaceuticals
KNSA
$2.71B
| $1.46M | 0.01% |
+84,313
| New | +$1.46M |
|
|
LJPC
348
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.46M | 0.01% |
50,000
+28,925
| +137% | +$844K |
|
349
Snap
SNAP
$12.3B
| $1.4M | 0.01% |
+106,843
| New | +$1.4M |
|
350
Verrica Pharmaceuticals
VRCA
$47.8M
| $1.38M | 0.01% |
+7,005
| New | +$1.38M |
|